文献
J-GLOBAL ID:201902256300087919
整理番号:19A1562990
ラベプラゾール摂取はカペシタビンおよびその代謝物,5′-デオキシ-5-フルオロシチジン,5′-デオキシ-5-フルオロウリジンおよび5-フルオロウラシルへの全身曝露に影響しない【JST・京大機械翻訳】
Rabeprazole intake does not affect systemic exposure to capecitabine and its metabolites, 5′-deoxy-5-fluorocytidine, 5′-deoxy-5-fluorouridine, and 5-fluorouracil
著者 (10件):
Sekido Masae
(Division of Cancer Cell Biology, Department of Pharmaceutical Science, Showa University School of Pharmacy, Tokyo, Japan)
,
Fujita Ken-ichi
(Division of Cancer Cell Biology, Department of Pharmaceutical Science, Showa University School of Pharmacy, Tokyo, Japan)
,
Kubota Yutaro
(Division of Medical Oncology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan)
,
Ishida Hiroo
(Division of Medical Oncology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan)
,
Takahashi Takehiro
(Division of Medical Oncology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan)
,
Ohkuma Ryotaro
(Division of Medical Oncology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan)
,
Tsunoda Takuya
(Division of Medical Oncology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan)
,
Ishikawa Fumihiro
(Division of Cancer Cell Biology, Department of Pharmaceutical Science, Showa University School of Pharmacy, Tokyo, Japan)
,
Shibanuma Motoko
(Division of Cancer Cell Biology, Department of Pharmaceutical Science, Showa University School of Pharmacy, Tokyo, Japan)
,
Sasaki Yasutsuna
(Division of Medical Oncology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan)
資料名:
Cancer Chemotherapy and Pharmacology
(Cancer Chemotherapy and Pharmacology)
巻:
83
号:
6
ページ:
1127-1135
発行年:
2019年
JST資料番号:
W4134A
ISSN:
1432-0843
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
ドイツ (DEU)
言語:
英語 (EN)